Supplementary Figures – Turalio Risk Evaluation and Mitigation Strategy for treatment of tenosynovial giant cell tumor: framework and experience
Supplemental Figure 1. Modified FDA framework for benefit-risk counseling to patients about drugs with a REMS* 
Supplementary Figure 2. Turalio® REMS Patient Enrollment Form 
Supplementary Figure 3. Turalio® REMS Prescriber Enrollment Form 
Supplementary Figure 4. Turalio® REMS Liver Adverse Event Reporting Form 
Supplemental Figure 5. Turalio® REMS Pharmacy Enrollment Form 
Supplemental Figure 6. Turalio REMS framework
Daiichi Sankyo, Inc.